Monitoring treatment response in EGFR mutant non-small cell lung cancer patients using mutational load in circulating cell-free tumour DNA.
2015
e19089 Background: The identification of activating EGFR mutations is essential for deciding therapy of non-small cell lung cancer (NSCLC) patients. Although evaluation of tumour biopsy material is...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI